Intrinsic Value of S&P & Nasdaq Contact Us

Cerus Corporation CERS NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
3/7 Pass
SharesGrow Intrinsic Value
$0.61
-69.8%
Analyst Price Target
$4.00
+98%

Cerus Corporation (CERS) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 7 recommend buying, 3 recommend holding, and 0 recommend selling.

The analyst consensus price target for CERS is $4.00, representing a +98.0% upside from the current price of $2.02. Price targets range from a low of $3.00 to a high of $5.00.

Analyst Consensus — CERS

Buy
Strong Buy
0
Buy
7
Hold
3
Sell
0
Strong Sell
0
10 analysts
Price Targets
Consensus$4.00
High$5.00
Low$3.00
Median$4.00
Last Month Avg-
Last Quarter Avg-
Last Year Avg-
All-Time Count3
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message